We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current CRBP market cap is 594.71M. The company's latest EPS is USD -4.1737 and P/E is -13.38.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -17.3M | -8.19M | -9.49M | -10.1M | -9.62M |
| Net Income | -17.75M | -8.78M | -10.05M | -8.02M | -6.9M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 36.14M | 3.94M | 882k | 0 | 0 |
| Operating Income | -77.1M | -122.81M | -55.99M | -39.84M | -45.08M |
| Net Income | -71.45M | -111.27M | -45.64M | -42.35M | -44.6M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 51.65M | 43.72M | 36.28M | 28.27M | 125.74M |
| Total Liabilities | 35.19M | 34.2M | 35.97M | 35.18M | 28.78M |
| Total Equity | 16.46M | 9.52M | 311k | -6.91M | 96.97M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 49.14M | 102.3M | 107.73M | 66.31M | 28.27M |
| Total Liabilities | 42.98M | 57.02M | 38.62M | 33.32M | 35.18M |
| Total Equity | 6.16M | 45.28M | 69.11M | 32.99M | -6.91M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -15.12M | -22.92M | -30.09M | -36.1M | -7.97M |
| Investing | 5.55M | 14.36M | 25.25M | 35.64M | -98.24M |
| Financing | -113k | -95k | -916k | -2.82M | 106.58M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -45.72M | -99.69M | -48.18M | -37.54M | -36.1M |
| Investing | -2.74M | -485k | -73.42M | 30.07M | 35.64M |
| Financing | 38.47M | 154.88M | 60.82M | -534k | -2.82M |
| Market Cap | 594.71M |
| Price to Earnings Ratio | -13.38 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 43.47 |
| Price to Book Ratio | -86.41 |
| Dividend Yield | - |
| Shares Outstanding | 10.69M |
| Average Volume (1 week) | 187.87k |
| Average Volume (1 Month) | 266.22k |
| 52 Week Change | 753.53% |
| 52 Week High | 61.18 |
| 52 Week Low | 3.0334 |
| Spread (Intraday) | 2.87 (4.87%) |
| Company Name | Corbus Pharmaceuticals Holdings Inc |
| Address |
850 new burton road dover, delaware 19904 |
| Website | https://www.corbuspharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
